Replies to post #129263 on Biotech Values

[pharmaclown35]

Yes, I agree. Also recently just realised that Incyte's JAK inhibitor doesn't even come to market until 2015. It's still a long ways away - somewhat. the earliest oral RA drug should be Rigel, followed by PFE's if I'm not mistaken.